Lumicell to Participate in Upcoming Conferences
Wellesley, Mass., September 5, 2017— Lumicell, Inc., a technology leader in the field of image-guided cancer surgery, announced today that management will participate in two upcoming September meetings, including: “We are delighted to represent Lumicell at these important industry meetings and look forward to providing further updates on our progress with the LUM System in […]
Lumicell Announces Product Development Progress with LUM015 in Lumicell System for Image-guided Cancer Surgery
Product innovation continues to advance under scientific leadership of company’s founder, W. David Lee Wellesley, Mass., Aug. 10, 2017— Lumicell, Inc., a technology leader in the field of image-guided cancer surgery, today announced the company’s progress with its product development of the Lumicell System, as well as the expansion of patent protection for the company’s product […]
Lumicell Appoints Kelly Londy as Chief Executive Officer, Announces Additional Financing
Wellesley, Mass., July 12, 2017 – The Board of Directors of Lumicell, Inc., a leader in the field of image-guided cancer surgery, announced today the appointment of Kelly Londy as Chief Executive Officer and member of the Board of Directors. W. David Lee, Founder of Lumicell, has moved into the role of President and Chief Scientific […]
Lumicell Appoints Felix Geissler, M.D., Ph.D. as Chief Medical Officer
Wellesley, Mass., June 28, 2017 – Lumicell, a leader in the field of image-guided cancer surgery, today announced the appointment of Felix Geissler, M.D., Ph.D. as Chief Medical Officer. As a central member of Lumicell’s senior executive team, he will drive the clinical direction of the company and will work closely with the R&D and marketing teams […]
Lumicell Awarded Direct Phase II Small Business Innovation Research (SBIR) Grant from the National Cancer Institute to Conduct Multi-Center Pivotal Study
Funding will Support Trial of the Lumicell Margin Assessment System (MAS) in Breast Cancer Surgery Wellesley, Mass., August 9, 2016 – Lumicell, a leader in the field of image-guided surgery, today announced that the National Cancer Institute (NCI) has awarded the Company a Phase II Small Business Innovation Research (SBIR) grant to fund a prospective multi-center pivotal […]
Lumicell Successfully Completes Phase 2a Feasibility Study
Revolutionary Approach to Imaging Tumor Cells Achieved 100% Detection of Residual Cancer and Well Tolerated in First Patient Samples Poster Presentation of Trial Findings at The American Society of Breast Surgeons Annual Meeting Wellesley, Mass., April 13, 2016 – Lumicell, a leader in the field of image-guided cancer surgery, today announced it successfully completed its Phase 2a […]
Lumicell Publishes Data Supporting LUM015, Fluorescent Probe for Imaging Cancer, in Science Translational Medicine
Revolutionary Approach to Imaging Tumor Cells Demonstrated to be Well Tolerated in First Patient Samples Wellesley, Mass., January 6, 2016 – Lumicell, a leader in the field of image-guided cancer surgery, today announced the publication of research supporting the Company’s groundbreaking protease-activated fluorescent imaging probe, LUM015, in Science Translational Medicine. The research highlights the use of LUM015 […]
Lumicell Announces FDA Approval to Launch Feasibility Study in Gastrointestinal Cancers
Trial is funded by National Cancer Institute’s SPORE program Wellesley, Mass., September 10, 2015 – Lumicell, a leader in the field of image-guided cancer surgery, has received approval from the U.S. Food and Drug Administration (FDA) to launch a feasibility (pilot) study in gastrointestinal cancers. The study will focus on imaging tissue in patients with esophageal, […]
Lumicell Announces FDA Approval to Launch Feasibility Study
Trial is funded by National Cancer Institute grant Wellesley, Mass., May 20, 2015 – Lumicell, a leader in the field of image-guided cancer surgery, has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to launch a feasibility (pilot) study for intraoperative imaging of breast cancer during surgery. The study will […]
Lumicell Phase 1 Results Presented at SSO 2015 Annual Cancer Symposium
Phase 1 Results Also Presented at AACR 2015 Annual Meeting Wellesley, Mass., May 8, 2015 – Lumicell, a leader in the field of image-guided cancer surgery, announced that Phase 1 trial results were recently presented at the SSO 2015 Annual Cancer Symposium in March and the AACR 2015 Annual Meeting in April. Both sessions were presented […]
